Interacting Drugs |
Cilazapril vs DPP-IV Inhibitors |
Security Level |
 |
Mechanism |
DPP-IV Inhibitors: May enhance the adverse/toxic effect of ACE Inhibitors. Specifically, the risk of angioedema may be increased. |
Management |
Monitor therapy |
Cilazapril vs DPP-IV Inhibitors
Post Review about Cilazapril vs DPP-IV Inhibitors Click here to cancel reply.
Other Interactions of Cilazapril
Other Interactions of DPP-IV Inhibitors
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.